Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers

Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers

Submitted by admin on July 15, 2012 - 11:22am
Source: 
Seeking Alpha
News Tags: 
Alkermes
Medivation
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Questcor Pharmaceuticals
Arena Pharmaceuticals
Seattle Genetics
Incyte
United Therapeutics
Amarin
ONYX Pharmaceuticals
Pharmacyclics
Human Genome Sciences
Theravance
Headline: 
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers

Do Not Allow Advertisers to Use My Personal information